Showing results (111-120 of 120) with videos related to
Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Cell Reports. Medicine|October 16, 2024
A phase 2 trial of gemcitabine plus toripalimab for cisplatin-ineligible patients with recurrent or metastatic nasopharyngeal carcinomaXiong Zou, Xi Ding, Zheng-Kai Feng, et al.Ebiomedicine|June 29, 2026
A preS2 aa1-26-specific humoural response marks functional cure in chronic HBV infectionYou-Yuan Wang, Jun-Liang Fu, Wen-Xin Wang, et al.Hepatology International|September 15, 2022
Reduction of natural killer cells is associated with poor outcomes in patients with hepatitis B virus-related acute-on-chronic liver failureHua-Jie Li, Ning Yang, Xiuying Mu, et al.Cell Reports. Medicine|November 11, 2023
Efficacy of sequential chemoradiotherapy combined with toripalimab in de novo metastatic nasopharyngeal carcinoma: A phase II trialSi-Yuan Chen, Xiao-Tong Duan, Hui-Feng Li, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 4, 2025
Radiation-induced rhinosinusitis in patients with nasopharyngeal carcinomaSi-Yuan Chen, Xiao-Tong Duan, Rui-Ling Xie, et al.Molecular Biomedicine|December 9, 2025
Clinicopathological characteristics, genetic aberrations, and optimized treatment strategies in double-hit and triple-hit lymphoma: a multi-center cohort studyYi-Ge Shen, Meng-Meng Ji, Qing Shi, et al.NEJM Evidence|April 22, 2025
Induction versus Concurrent Chemotherapy for Advanced Nasopharyngeal CarcinomaPei-Yu Huang, Xu-Yin Chen, Xi Ding, et al.Cancer Cell|January 19, 2024
Refining the 8th edition TNM classification for EBV related nasopharyngeal carcinomaXiao-Jing Du, Gao-Yuan Wang, Xiao-Dong Zhu, et al.Lancet (London, England)|February 26, 2023
Hyperfractionation compared with standard fractionation in intensity-modulated radiotherapy for patients with locally advanced recurrent nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trialRui You, You-Ping Liu, Yu-Long Xie, et al.Cancer Communications (London, England)|May 9, 2025
Extranodal diffuse large B-cell lymphoma: Clinical and molecular insights with survival outcomes from the multicenter EXPECT studySi-Yuan Chen, Peng-Peng Xu, Ru Feng, et al.Pageof 12